1. Home
  2. BANC vs GERN Comparison

BANC vs GERN Comparison

Compare BANC & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BANC
  • GERN
  • Stock Information
  • Founded
  • BANC 1941
  • GERN 1990
  • Country
  • BANC United States
  • GERN United States
  • Employees
  • BANC N/A
  • GERN N/A
  • Industry
  • BANC Major Banks
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BANC Finance
  • GERN Health Care
  • Exchange
  • BANC Nasdaq
  • GERN Nasdaq
  • Market Cap
  • BANC 2.5B
  • GERN 2.5B
  • IPO Year
  • BANC N/A
  • GERN 1996
  • Fundamental
  • Price
  • BANC $16.22
  • GERN $3.66
  • Analyst Decision
  • BANC Buy
  • GERN Strong Buy
  • Analyst Count
  • BANC 11
  • GERN 10
  • Target Price
  • BANC $17.36
  • GERN $6.95
  • AVG Volume (30 Days)
  • BANC 2.8M
  • GERN 9.5M
  • Earning Date
  • BANC 10-22-2024
  • GERN 11-07-2024
  • Dividend Yield
  • BANC 2.46%
  • GERN N/A
  • EPS Growth
  • BANC N/A
  • GERN N/A
  • EPS
  • BANC N/A
  • GERN N/A
  • Revenue
  • BANC $412,570,000.00
  • GERN $29,480,000.00
  • Revenue This Year
  • BANC N/A
  • GERN $30,930.80
  • Revenue Next Year
  • BANC $10.27
  • GERN $315.72
  • P/E Ratio
  • BANC N/A
  • GERN N/A
  • Revenue Growth
  • BANC N/A
  • GERN 9199.68
  • 52 Week Low
  • BANC $11.36
  • GERN $1.64
  • 52 Week High
  • BANC $16.92
  • GERN $5.34
  • Technical
  • Relative Strength Index (RSI)
  • BANC 57.84
  • GERN 29.99
  • Support Level
  • BANC $15.93
  • GERN $3.98
  • Resistance Level
  • BANC $16.88
  • GERN $4.50
  • Average True Range (ATR)
  • BANC 0.44
  • GERN 0.21
  • MACD
  • BANC 0.02
  • GERN -0.05
  • Stochastic Oscillator
  • BANC 67.21
  • GERN 3.45

About BANC Banc of California Inc.

Banc of California Inc is a financial holding company. It offers banking and financial services. The company's services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: